Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
暂无分享,去创建一个
Paolo Vineis | Peter Kraft | Bin Zhu | Nilanjan Chatterjee | Nathaniel Rothman | Akinyemi I Ojesina | Mark P Purdue | Anthony Staines | Kenneth Offit | Amy Hutchinson | Stephen J Chanock | Alexandra Nieters | Charles Lawrence | Qing Lan | Neil E Caporaso | Paolo Boffetta | Tongzhang Zheng | Edward Giovannucci | Nikolaus Becker | Christine Mayr | Meredith Yeager | Huihuang Yan | Mads Melbye | Wendy Cozen | Henrik Hjalgrim | Federico Canzian | Jacques Riby | Kari E North | Paul Brennan | Joseph Vijai | Bengt Glimelius | Sonja I Berndt | James R Cerhan | Andrew L Feldman | Jacqueline Clavel | Lesley F Tinker | J. Cerhan | C. Mayr | N. Rothman | S. Chanock | P. Vineis | R. Vermeulen | A. Feldman | H. Adami | N. Chatterjee | P. Kraft | K. Offit | S. Sanjosé | M. Yeager | Zhaoming Wang | A. Hutchinson | E. Giovannucci | C. Skibola | E. Weiderpass | L. Burdette | Charles C. Chung | S. Berndt | P. Brennan | S. Slager | J. Vijai | K. North | P. Boffetta | Ju-Hyun Park | F. Canzian | A. I. Ojesina | Q. Lan | M. Melbye | P. Bracci | R. Severson | B. Zhu | A. Staines | S. Ansell | J. Riby | N. Caporaso | E. Brown | H. Hjalgrim | Huihuang Yan | L. Morton | B. Glimelius | B. Hicks | R. Travis | N. Becker | W. Cozen | B. Birmann | B. Bassig | M. Purdue | L. Conde | T. Zheng | Yawei Zhang | L. Goldin | Y. Benavente | A. Novak | Charles Lawrence | M. McMaster | Zhaoming Wang | Lynn R Goldin | Susan L Slager | Paige M Bracci | Elisabete Weiderpass | Charles C Chung | Laurie Burdette | W Ryan Diver | Hans-Olov Adami | Yawei Zhang | Anne J Novak | Stephen M Ansell | A. Nieters | A. Monnereau | Lauren R. Teras | K. E. Smedby | C. Vajdic | B. Link | L. Tinker | J. Clavel | Richard K Severson | Silvia de Sanjose | Lucia Conde | Alain Monnereau | Rebecca Montalvan | Ann Maria | Yolanda Benavente | Lenka Foretova | Marc Maynadie | James McKay | Alex Smith | Lindsay M Morton | Ruth C Travis | Jonathan N Hofmann | Christine F Skibola | Elizabeth E Brown | Ju-Hyun Park | Brian K Link | Rebecca D Jackson | J. Hofmann | Lauren R Teras | Roel C H Vermeulen | Claire M Vajdic | Karin E Smedby | Brenda M Birmann | Mary L McMaster | Jianqing Zhang | Shengchao Alfred Li | Geffen Kleinstern | Mervin M Fansler | Belynda D Hicks | Caroline M Besson | Nisha Pradhan | Bryan A Bassig | Shengchao A Li | Charles E. Lawrence | G. Kleinstern | Nisha Pradhan | C. Besson | Jianqing Zhang | Ann Maria | Rebecca Montalvan | Alex Smith | Mervin M. Fansler | M. Maynadie | R. Jackson | L. Foretova | W. Diver | J. Mckay | P. Brennan | T. Zheng | Laurie A. Burdette | E. Brown | R. Jackson | Silvia de Sanjosé
[1] Howard Y. Chang,et al. DDX5 and its associated lncRNA Rmrp modulate Th17 cell effector functions , 2015, Nature.
[2] N. Harris,et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.
[3] Douglas F. Easton,et al. Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.
[4] M. White,et al. RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival , 2006, Cell.
[5] Paolo Vineis,et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma , 2014, Nature Genetics.
[6] J. Miguel,et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals , 2007, Leukemia.
[7] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[8] K. Hemminki,et al. Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms , 2005, Leukemia.
[9] David I. Smith,et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. , 2011, Blood.
[10] R. Pfeiffer,et al. Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation. , 2010, Blood.
[11] P. Visscher,et al. Common SNPs explain a large proportion of heritability for human height , 2011 .
[12] J. Cerhan,et al. Genetic susceptibility to diffuse large B‐cell lymphoma in a pooled study of three Eastern Asian populations , 2015, European journal of haematology.
[13] Chia-Cheng Yu,et al. MicroRNA-324 in Human Cancer: miR-324-5p and miR-324-3p Have Distinct Biological Functions in Human Cancer. , 2016, Anticancer research.
[14] N. Gray,et al. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia. , 2013, Blood.
[15] Julie L. Yang,et al. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression , 2013, Genes & development.
[16] Ivo L. Hofacker,et al. Vienna RNA secondary structure server , 2003, Nucleic Acids Res..
[17] J. Witte,et al. Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness , 2015, Nature Communications.
[18] Jian Gu,et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A , 2016, Nature Genetics.
[19] J. Mages,et al. DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response1 , 2006, The Journal of Immunology.
[20] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[21] Adele Seniori Costantini,et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. , 2010, Blood.
[22] Alan M. Kwong,et al. A reference panel of 64,976 haplotypes for genotype imputation , 2015, Nature Genetics.
[23] J. Cerhan,et al. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[24] Michael A. Teitell,et al. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] Yan Li,et al. A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.
[26] J. Laine,et al. The protooncogene TCL1 is an Akt kinase coactivator. , 2000, Molecular cell.
[27] G. Barber,et al. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.
[28] J. Koshiol,et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. , 2010, Journal of the National Cancer Institute.
[29] A. Viale,et al. Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies , 2013, PLoS genetics.
[30] D. Krappmann,et al. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies , 2014, Oncogene.
[31] M. Stern,et al. The TCL1A Oncoprotein Interacts Directly with the NF-κB Inhibitor IκB , 2009, PloS one.
[32] S. Gerson,et al. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[34] M. White,et al. Ral GTPases and cancer: linchpin support of the tumorigenic platform , 2008, Nature Reviews Cancer.
[35] A. Brooks-Wilson,et al. Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[36] Christine Mayr,et al. Widespread intronic polyadenylation diversifies immune cell transcriptomes , 2018, Nature Communications.
[37] Mark I McCarthy,et al. Genomic inflation factors under polygenic inheritance , 2011, European Journal of Human Genetics.
[38] David F. Kashatus. Ral GTPases in tumorigenesis: emerging from the shadows. , 2013, Experimental cell research.
[39] U. Klein,et al. Article Transcriptional Regulation of Germinal Center B and Plasma Cell Fates by Dynamical Control of Irf4 , 2022 .
[40] L. Peterson,et al. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. , 2013, American journal of clinical pathology.
[41] Nilanjan Chatterjee,et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.
[42] Paolo Vineis,et al. Genome-wide Association Study Identifies Multiple Risk Loci for Chronic Lymphocytic Leukemia , 2013, Nature Genetics.
[43] P. Visscher,et al. Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.
[44] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[45] C. Mayr. Regulation by 3'-Untranslated Regions. , 2017, Annual review of genetics.
[46] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[47] Ralf Schmidt,et al. A comprehensive analysis of 3′ end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation , 2015, bioRxiv.
[48] Philip A. Ewels,et al. Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C , 2015, Nature Genetics.
[49] Dan Xie,et al. Extensive Variation in Chromatin States Across Humans , 2013, Science.
[50] K. Honda,et al. Negative regulation of Toll-like-receptor signaling by IRF-4. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Koshiol,et al. Chronic immune stimulation and subsequent Waldenström macroglobulinemia. , 2008, Archives of internal medicine.
[52] R. Vemuganti,et al. MicroRNA miR-324-3p Induces Promoter-Mediated Expression of RelA Gene , 2013, PloS one.
[53] R. Hardy,et al. A role for IRF4 in the development of CLL. , 2013, Blood.
[54] U. Klein,et al. The diverse roles of IRF4 in late germinal center B‐cell differentiation , 2012, Immunological reviews.
[55] Stephen Chanock,et al. Population Substructure and Control Selection in Genome-Wide Association Studies , 2008, PloS one.
[56] Jonathan M. Cairns,et al. Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters , 2016, Cell.
[57] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[58] F. Slack,et al. The Inescapable Influence of Noncoding RNAs in Cancer. , 2015, Cancer research.
[59] Y. Sekine,et al. Regulation of STAT3-mediated signaling by LMW-DSP2 , 2006, Oncogene.
[60] S. Hodge,et al. Familial cosegregation of rare genetic variants with disease in complex disorders , 2012, European Journal of Human Genetics.
[61] J. Cerhan,et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes , 2016, CA: a cancer journal for clinicians.
[62] M. Björkholm,et al. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. , 2008, Blood.
[63] Stefan Boehringer,et al. Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. , 2006, American journal of human genetics.
[64] Burton B. Yang,et al. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression , 2007, Proceedings of the National Academy of Sciences.
[65] Daniel R. Caffrey,et al. A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes , 2013, Science.
[66] N. Munshi,et al. MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia. , 2014, Blood.
[67] P. Donnelly,et al. Inference of population structure using multilocus genotype data. , 2000, Genetics.
[68] P. Morel,et al. TCL1 expression patterns in Waldenström macroglobulinemia , 2016, Modern Pathology.
[69] Y. Pekarsky,et al. Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. , 2012, Blood.